Centiva Capital, LP Biom X Inc. Transaction History

Centiva Capital, LP

  • $4.79 Billion
  • Q3 2024

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2020

May 15, 2020
SELL
$61.2 - $104.4 $1.26 Million - $2.15 Million
-20,609 Closed
0 $0
Q4 2019

Feb 14, 2020
BUY
$61.3 - $108.0 $1.26 Million - $2.23 Million
20,609 New
20,609 $200,000

Others Institutions Holding PHGE

# of Institutions
2
Shares Held
301K
Call Options Held
0
Put Options Held
0
View Full List

About BiomX Inc.

PHGE Quotes by TradingView
  • Ticker PHGE
  • Exchange NYSE
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 29,982,300
  • Market Cap $19.2M
  • Description
  • BiomX Inc., a clinical-stage microbiome company, develops products using natural and engineered phage technologies designed to target and kill specific harmful bacteria. It targets bacteria that affect the appearance of skin, as well as chronic diseases, such as inflammatory bowel diseases (IBD), primary sclerosing cholangitis (PSC), cystic fibr...
More about PHGE
Track This Portfolio

Track Centiva Capital, LP Portfolio

Follow Centiva Capital, LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Centiva Capital, LP, based on Form 13F filings with the SEC.

News

Stay updated on Centiva Capital, LP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email